Search

Your search keyword '"Hiley C"' showing total 469 results

Search Constraints

Start Over You searched for: Author "Hiley C" Remove constraint Author: "Hiley C"
469 results on '"Hiley C"'

Search Results

2. Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK

3. 77P Experience pooling control arms within a complex phase I drug-radiotherapy (RT) platform trial

4. Neutrophil–Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer

5. Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK Cohort

6. Antiferromagnetism at T > 500 K in the Layered Hexagonal Ruthenate SrRu2O6

7. P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC

8. Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters

9. MO-0467 Impact of the COVID-19 pandemic on patient outcomes after curative-intent radiotherapy in the UK

13. EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)

14. EP08.03-005 HALT - Targeted Therapy with or without Dose-Intensified Radiotherapy in Oligo-Progressive Disease in Oncogene Addicted Lung Tumours

15. 28P Identification of convergent gene repression mechanisms through integrative genomic and DNA methylation analysis in NSCLC

16. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

17. Current applications and future development of magnetic resonance fingerprinting in diagnosis, characterization, and response monitoring in cancer

18. A Mitochondria-Targeted S-Nitrosothiol Modulates Respiration, Nitrosates Thiols, and Protects against Ischemia-Reperfusion Injury

24. PH-0274 NLR & ALC as prognostic markers in patients treated with curative intent radiotherapy for NSCLC

25. OC-0533 Two Centre Feasibility study of single fraction lung stereotactic ablative radiotherapy (SABR)

29. Using DNA sequencing data to quantify T cell fraction and therapy response

32. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

33. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

34. Stereotactic ablative body radiotherapy (SABR) combined with Immunotherapy (L19-IL2) in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

35. In silico patent searching reveals a new cannabinoid receptor

36. Corrigendum to “73 - Five years of stereotactic radiotherapy for early lung cancer: Biopsy rates, outcomes and implications” [Lung Cancer, 139, 1, (January 2020) Page S31]

41. Neutrophil lymphocyte ratio as a prognostic marker in patients treated with curative intent radiotherapy for non-small cell lung cancer

45. P1.04-43 PD-RAD: A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-Small Cell Lung Cancer - Trial in Progress

46. P2.01-08 Clinical Trial in Progress: CONCORDE - A Phase 1B Study of Novel Agents in Combination with Conventional Radiotherapy in NSCLC

Catalog

Books, media, physical & digital resources